Acurx Pharmaceuticals

ACXPNASDAQ
$2.42
0.031.26%
Pre-Market: 9:25 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$14.00
Lowest Price Target1
$12.00
Consensus Price Target1
$12.67

want to know what
the Bulls & Bears Say?

Acurx Pharmaceuticals (NASDAQ:ACXP) Stock, Analyst Ratings, Price Targets, Forecasts

Acurx Pharmaceuticals Inc has a consensus price target of $12.67 based on the ratings of 3 analysts. The high is $14 issued by Alliance Global Partners on October 20, 2022. The low is $12 issued by HC Wainwright & Co. on May 16, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 16, 2024, March 19, 2024, and February 28, 2024, respectively. With an average price target of $12.67 between HC Wainwright & Co., there's an implied 423.42% upside for Acurx Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
0
0
0
0
Mar
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Alliance Global Partners
Maxim Group

1calculated from analyst ratings

Analyst Ratings for Acurx Pharmaceuticals

Buy NowGet Alert
05/16/2024Buy Now395.87%HC Wainwright & Co.
Ed Arce
$12 → $12ReiteratesBuy → BuyGet Alert
03/19/2024Buy Now395.87%HC Wainwright & Co.
Ed Arce
$14 → $12MaintainsBuyGet Alert
02/28/2024Buy Now478.51%HC Wainwright & Co.
Ed Arce
→ $14ReiteratesBuy → BuyGet Alert
12/15/2023Buy Now478.51%HC Wainwright & Co.
Ed Arce
$13 → $14MaintainsBuyGet Alert
11/15/2023Buy Now437.19%HC Wainwright & Co.
Ed Arce
→ $13ReiteratesBuy → BuyGet Alert
09/13/2023Buy Now437.19%HC Wainwright & Co.
Ed Arce
→ $13ReiteratesBuy → BuyGet Alert
08/15/2023Buy Now437.19%HC Wainwright & Co.
Ed Arce
$14 → $13MaintainsBuyGet Alert
05/15/2023Buy Now478.51%HC Wainwright & Co.
Ed Arce
→ $14ReiteratesBuy → BuyGet Alert
04/11/2023Buy Now478.51%HC Wainwright & Co.
Ed Arce
→ $14Reiterates → BuyGet Alert
03/17/2023Buy Now478.51%HC Wainwright & Co.
Ed Arce
→ $14Reiterates → BuyGet Alert
12/19/2022Buy Now478.51%HC Wainwright & Co.
Ed Arce
→ $14Initiates → BuyGet Alert
10/20/2022Buy Now478.51%Alliance Global Partners
James Molloy
→ $14Initiates → BuyGet Alert
11/29/2021Buy Now395.87%Maxim Group
Jason McCarthy
Initiates → BuyGet Alert

FAQ

Q

What is the target price for Acurx Pharmaceuticals (ACXP) stock?

A

The latest price target for Acurx Pharmaceuticals (NASDAQ:ACXP) was reported by HC Wainwright & Co. on May 16, 2024. The analyst firm set a price target for $12.00 expecting ACXP to rise to within 12 months (a possible 395.87% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acurx Pharmaceuticals (ACXP)?

A

The latest analyst rating for Acurx Pharmaceuticals (NASDAQ:ACXP) was provided by HC Wainwright & Co., and Acurx Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Acurx Pharmaceuticals (ACXP)?

A

There is no last upgrade for Acurx Pharmaceuticals

Q

When was the last downgrade for Acurx Pharmaceuticals (ACXP)?

A

There is no last downgrade for Acurx Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Acurx Pharmaceuticals (ACXP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acurx Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acurx Pharmaceuticals was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.

Q

Is the Analyst Rating Acurx Pharmaceuticals (ACXP) correct?

A

While ratings are subjective and will change, the latest Acurx Pharmaceuticals (ACXP) rating was a reiterated with a price target of $12.00 to $12.00. The current price Acurx Pharmaceuticals (ACXP) is trading at is $2.42, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch